These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1762106)

  • 1. Thyroid cancer: epidemiological study of thyroid cancer in A-bomb survivors from extended life span study cohort in Hiroshima.
    Ezaki H; Takeichi N; Yoshimoto Y
    J Radiat Res; 1991 Mar; 32 Suppl():193-200. PubMed ID: 1762106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid Dysfunction and Autoimmune Thyroid Diseases Among Atomic Bomb Survivors Exposed in Childhood.
    Imaizumi M; Ohishi W; Nakashima E; Sera N; Neriishi K; Yamada M; Tatsukawa Y; Takahashi I; Fujiwara S; Sugino K; Ando T; Usa T; Kawakami A; Akahoshi M; Hida A
    J Clin Endocrinol Metab; 2017 Jul; 102(7):2516-2524. PubMed ID: 28472357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Thyroid cancer: reports up to date and a review.
    Takeichi N; Ezaki H; Dohi K
    J Radiat Res; 1991 Mar; 32 Suppl():180-8. PubMed ID: 1762104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parathyroid tumors in atomic bomb survivors in Hiroshima: a review.
    Takeichi N; Dohi K; Ito H; Yamamoto H; Mabuchi K; Yamamoto T; Shimaoka K; Yokoro K
    J Radiat Res; 1991 Mar; 32 Suppl():189-92. PubMed ID: 1762105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence rate of thyroid diseases among autopsy cases of the atomic bomb survivors in Hiroshima, 1951-1985.
    Yoshimoto Y; Ezaki H; Etoh R; Hiraoka T; Akiba S
    Radiat Res; 1995 Mar; 141(3):278-86. PubMed ID: 7871154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologically-based modeling of radiation risk and biomarker prevalence for papillary thyroid cancer in Japanese a-bomb survivors 1958-2005.
    Kaiser JC; Misumi M; Furukawa K
    Int J Radiat Biol; 2021; 97(1):19-30. PubMed ID: 32573332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987.
    Thompson DE; Mabuchi K; Ron E; Soda M; Tokunaga M; Ochikubo S; Sugimoto S; Ikeda T; Terasaki M; Izumi S
    Radiat Res; 1994 Feb; 137(2 Suppl):S17-67. PubMed ID: 8127952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term trend of thyroid cancer risk among Japanese atomic-bomb survivors: 60 years after exposure.
    Furukawa K; Preston D; Funamoto S; Yonehara S; Ito M; Tokuoka S; Sugiyama H; Soda M; Ozasa K; Mabuchi K
    Int J Cancer; 2013 Mar; 132(5):1222-6. PubMed ID: 22847218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation exposure and thyroid cancer incidence among Hiroshima and Nagasaki residents.
    Prentice RL; Kato H; Yoshimoto K; Mason M
    Natl Cancer Inst Monogr; 1982; 62():207-12. PubMed ID: 7167191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies.
    Ron E; Lubin JH; Shore RE; Mabuchi K; Modan B; Pottern LM; Schneider AB; Tucker MA; Boice JD
    Radiat Res; 1995 Mar; 141(3):259-77. PubMed ID: 7871153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The proportion of thyroid cancers in the Japanese atomic bomb survivors associated with natural background radiation.
    Little MP
    J Radiol Prot; 2002 Sep; 22(3):279-91. PubMed ID: 12375789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Papillary microcarcinoma of the thyroid among atomic bomb survivors: tumor characteristics and radiation risk.
    Hayashi Y; Lagarde F; Tsuda N; Funamoto S; Preston DL; Koyama K; Mabuchi K; Ron E; Kodama K; Tokuoka S
    Cancer; 2010 Apr; 116(7):1646-55. PubMed ID: 20120034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer and non-cancer effects in Japanese atomic bomb survivors.
    Little MP
    J Radiol Prot; 2009 Jun; 29(2A):A43-59. PubMed ID: 19454804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer incidence in atomic bomb survivors. Part IV: Comparison of cancer incidence and mortality.
    Ron E; Preston DL; Mabuchi K; Thompson DE; Soda M
    Radiat Res; 1994 Feb; 137(2 Suppl):S98-112. PubMed ID: 8127954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Cancer risk among in utero-exposed survivors.
    Yoshimoto Y; Kato H; Schull WJ
    J Radiat Res; 1991 Mar; 32 Suppl():231-8. PubMed ID: 1762110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid diseases in atomic bomb survivors exposed in utero.
    Imaizumi M; Ashizawa K; Neriishi K; Akahoshi M; Nakashima E; Usa T; Tominaga T; Hida A; Sera N; Soda M; Fujiwara S; Yamada M; Maeda R; Nagataki S; Eguchi K
    J Clin Endocrinol Metab; 2008 May; 93(5):1641-8. PubMed ID: 18319305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid diseases in cohort studies of A-bomb survivors.
    Shimaoka K; Shibata Y; Akiba S
    Thyroidology; 1994 Aug; 6(2):37-41. PubMed ID: 7536448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant and benign ovarian neoplasms among atomic bomb survivors, Hiroshima and Nagasaki, 1950-80.
    Tokuoka S; Kawai K; Shimizu Y; Inai K; Ohe K; Fujikura T; Kato H
    J Natl Cancer Inst; 1987 Jul; 79(1):47-57. PubMed ID: 3474449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid disease 60 years after Hiroshima and 20 years after Chernobyl.
    Boice JD
    JAMA; 2006 Mar; 295(9):1060-2. PubMed ID: 16507808
    [No Abstract]   [Full Text] [Related]  

  • 20. Thyroid carcinoma in atomic bomb survivors Hiroshima and Nagasaki,
    Wood JW; Tamagaki H; Neriishi S; Sato T; Sheldon WF; Archer PG; Hamilton HB; Johnson KG
    Am J Epidemiol; 1969 Jan; 89(1):4-14. PubMed ID: 5762817
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.